Massachusetts

ProMIS Neurosciences Issues White Paper Entitled: “Not All Amyloid Beta Therapeutics Are Created Equal”

ProMIS Neurosciences Lead Product Candidate for Alzheimer's Disease Shows Improved Therapeutic Potency versus other Amyloid Beta-Directed Antibodies TORONTO and CAMBRIDGE, MA, Jan. 25, 2018 /PRNewswire/ - ProMIS Neurosciences, Inc., a…
Continue Reading »
Massachusetts

Pulmatrix Will Present Pulmazole Preclinical Data at the 8th Advances Against Aspergillosis Conference to be Held February 1 – 3, 2018

LEXINGTON, Mass., Jan. 24, 2018 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases announced today that it will present…
Continue Reading »
Massachusetts

Smart Speakers: Apple to sell 3.8 million HomePod speakers in 2018 for less than 10% market share says Strategy Analytics

BOSTON, Jan. 24, 2018 /PRNewswire/ -- Apple will finally launch its HomePod smart speaker on February 9th 2018 and will be hoping that its music-first approach will help it to…
Continue Reading »